ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Missouri » Geriatric Medicine

Top Geriatric Medicine Prescribers in Missouri

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MARJON GILLBANKS M.D.

Geriatric Medicine

6,945

$363K

359
330 are 65+

5%
patients receiving schedule two controlled substances

Avg: 8%

19%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$52
Average prescription price

Avg: $61

ABRAHAM BARAKE M.D.

Geriatric Medicine

7,023

$450K

442
411 are 65+

5%
patients receiving schedule two controlled substances

Avg: 8%

16%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$64
Average prescription price

Avg: $61

KARMEL CAROTHERS M.D.

Geriatric Medicine

7,309

$362K

371
336 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

12%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $61

JOHN CONNOLLY M.D.

Geriatric Medicine

8,776

$409K

483
433 are 65+

3%
patients receiving schedule two controlled substances

Avg: 8%

11%
patients receiving schedule three controlled substances

Avg: 13%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$47
Average prescription price

Avg: $61

KRISTI SHAUMEYER MD

Geriatric Medicine

9,404

$511K

331
262 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

25%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $61

POONAM JAIN M.D.

Geriatric Medicine

10,527

$584K

237
227 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 13%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$56
Average prescription price

Avg: $61

CHANTRI TRINH MD

Geriatric Medicine

11,605

$510K

339
282 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

17%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$44
Average prescription price

Avg: $61

RICHARD ONEILL M.D.

Geriatric Medicine

11,752

$690K

496
384 are 65+

3%
patients receiving schedule two controlled substances

Avg: 8%

16%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$59
Average prescription price

Avg: $61

TONY TANG M. D.

Geriatric Medicine

12,107

$542K

281
238 are 65+

15%
patients receiving schedule two controlled substances

Avg: 8%

19%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$45
Average prescription price

Avg: $61

JOHN MORLEY MD

Geriatric Medicine

12,908

$778K

396
339 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

17%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$60
Average prescription price

Avg: $61

JON DEDON M.D.

Geriatric Medicine

13,178

$918K

183
132 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 24%

$70
Average prescription price

Avg: $61

RAJAMANICKAM PURUSHOTHAMAN MD

Geriatric Medicine

14,089

$813K

455
401 are 65+

12%
patients receiving schedule two controlled substances

Avg: 8%

15%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$58
Average prescription price

Avg: $61

RIFFAT IMDAD M.D.

Geriatric Medicine

14,248

$771K

356
341 are 65+

14%
patients receiving schedule two controlled substances

Avg: 8%

18%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $61

MARIA DELA ROSA MD

Geriatric Medicine

14,847

$786K

602
562 are 65+

5%
patients receiving schedule two controlled substances

Avg: 8%

16%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$53
Average prescription price

Avg: $61

RAFI KEVORKIAN MD

Geriatric Medicine

15,047

$1.05M

402
242 are 65+

14%
patients receiving schedule two controlled substances

Avg: 8%

15%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$70
Average prescription price

Avg: $61

GRANT BARNUM D.O.

Geriatric Medicine

16,728

$925K

820
694 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

20%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$55
Average prescription price

Avg: $61

CHARLES CRECELIUS M.D.

Geriatric Medicine

16,844

$1.17M

557
530 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

13%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 24%

$69
Average prescription price

Avg: $61

KEVIN FARRELL D.O.

Geriatric Medicine

17,039

$925K

395
326 are 65+

13%
patients receiving schedule two controlled substances

Avg: 8%

21%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $61

MARK GUNBY

Geriatric Medicine

17,649

$870K

810
730 are 65+

4%
patients receiving schedule two controlled substances

Avg: 8%

9%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $61

MOHAMMED MOJID M.D.

Geriatric Medicine

17,755

$1.1M

518
342 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

23%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $61

ROSHAN SABAR M.D.

Geriatric Medicine

18,627

$919K

374
342 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

17%
patients receiving schedule three controlled substances

Avg: 13%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $61

PETER HOLT MD

Geriatric Medicine

18,894

$1.09M

859
832 are 65+

5%
patients receiving schedule two controlled substances

Avg: 8%

12%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$58
Average prescription price

Avg: $61

GOPAL NAIR MD

Geriatric Medicine

20,207

$950K

321
262 are 65+

22%
patients receiving schedule two controlled substances

Avg: 8%

33%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$47
Average prescription price

Avg: $61

PAMELA MABEN MD

Geriatric Medicine

22,490

$1M

856
727 are 65+

6%
patients receiving schedule two controlled substances

Avg: 8%

20%
patients receiving schedule three controlled substances

Avg: 13%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$45
Average prescription price

Avg: $61

DEATRICE KELLOGG MD

Geriatric Medicine

27,690

$1.7M

732
639 are 65+

8%
patients receiving schedule two controlled substances

Avg: 8%

20%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$61
Average prescription price

Avg: $61

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank